Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors
19 sept. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress
01 août 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Announces Second Quarter Financial Results Conference Call on August 1, 2017
18 juil. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., July 18, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics Announces Commercial Supply Agreement for EG-1962 with Oakwood Laboratories
06 juil. 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., July 06, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced that it has entered into a supply agreement and an amended and restated development...
Edge Therapeutics to Participate in the JMP Securities Life Science Conference
15 juin 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
08 juin 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management...
Edge Therapeutics to Present at Jefferies 2017 Global Healthcare Conference
02 juin 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., June 02, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics to Present at Bank of America Merrill Lynch 2017 Health Care Conference
10 mai 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., May 10, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics Reports First Quarter 2017 Financial Results and Continued Operational Progress
03 mai 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of...
Edge Therapeutics Announces Conference Call on May 3, 2017 to Discuss First Quarter 2017 Financial Results
21 avr. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., April 21, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management...